logo_new.jpg
ObsEva Hosts KOL Meeting on IVF Trends, Unmet Need and Market Potential of Nolasiban
17 juil. 2019 12h00 HE | ObsEva SA
                                         Company remains on track to submit Nolasiban MAA in the fourth quarter of 2019   GENEVA, Switzerland and BOSTON, MA -  July 17, 2019 – ObsEva SA (NASDAQ:...
logo_new.jpg
ObsEva SA to Host Key Opinion Leader Meeting on In Vitro Fertilization (IVF) July 17, 2019 in New York City
12 juil. 2019 01h00 HE | ObsEva SA
Geneva, Switzerland and Boston, MA – July 12, 2019– ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for...
Blogo_dark_tagline.jpg
Titan Pharmaceuticals Selects Life Sciences Business Intelligence CRM Innovator, TikaMobile, to Empower its Sales and MSL Teams
11 févr. 2019 14h00 HE | TikaMobile, Inc.
NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- TikaMobile, a premier cloud-based business intelligence  CRM provider for the life sciences industry, today announced that Titan Pharmaceuticals, Inc. has...
Blogo_dark_tagline.jpg
TikaMobile Launches TikaMSL, an Innovative Analytics CRM Platform for Medical Science Liaisons Designed to Drive Key Opinion Leader Development
30 avr. 2018 08h00 HE | TikaMobile, Inc.
NEW YORK, April 30, 2018 (GLOBE NEWSWIRE) -- TikaMobile, Inc., a cloud-based analytics and CRM software company focused on the life sciences industry, today announced the addition of TikaMSL to its...
Vaccinex logo
Vaccinex, Inc. to Host Key Opinion Leader Luncheon on Huntington’s Disease
30 janv. 2018 11h14 HE | Vaccinex, Inc.
ROCHESTER, N.Y., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc., a privately-held clinical-stage biotechnology company engaged in the discovery and development of human therapeutic monoclonal...
Hard Limits on Thought Leader Compensation Employed Less Often by Pharma
21 juil. 2011 12h06 HE | Cutting Edge Information
RESEARCH TRIANGLE PARK, NC and BOSTON, MA--(Marketwire - Jul 21, 2011) - As compliance and medical affairs teams prepare for the Sunshine Act, they are relying less on exact compensation limits for...
Thought Leader FMV Benchmarking Service Launches With Decade of Data
20 juil. 2011 10h02 HE | Cutting Edge Information
DURHAM, NC--(Marketwire - Jul 20, 2011) - Pharmaceutical consultancy Cutting Edge Information has launched a widely expanded benchmarking offering to help drug and medical device companies set...
Drug Manufacturers Pay European Key Opinion Leaders EUR 153-EUR 283 per Hour on Average
07 juil. 2011 10h03 HE | Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - Jul 7, 2011) - A new study of European fair-market value benchmarks found that drug manufacturers spend between EUR 153 and EUR 283 for a typical key...
Sunshine Act Impacts Drug Companies' Promotional Activities
28 juin 2011 12h08 HE | Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - Jun 28, 2011) - Although the Sunshine Act requires disclosures for grants and other funding of medical research, the majority of payment categories are...
Travel Costs for Key Opinion Leaders Come Under the Microscope
21 juin 2011 12h14 HE | Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - Jun 21, 2011) - As more companies get a firm handle on processes for determining fair-market value and setting physician fee schedules, payments for travel...